Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.1T | 1.2T | 1.0T | 1.1T |
| Cost of revenue | 620.5B | 639.3B | 605.9B | 596.3B |
| Gross profit | 506.8B | 512.5B | 442.9B | 466.9B |
| Operating expense | ||||
| Research & development | 413.4M | 605.1M | 622.6M | 373.3M |
| Selling general and admin | 324.3B | 333.6B | 283.8B | 292.3B |
| Other operating expenses | 10.3B | — | — | 6.6B |
| Operating income | 54.8B | 49.1B | 46.0B | 48.5B |
| Non operating interest income | ||||
| Income | 468.1M | 526.7M | 323.5M | 311.7M |
| Expense | 32.2B | 34.0B | 36.2B | 37.8B |
| Other income expense | — | — | — | — |
| Pretax income | 37.5B | 76.4B | -8.3B | 18.1B |
| Tax provision | -2.3B | 14.0B | -1.4B | 3.7B |
| Net income | 39.8B | 62.4B | -6.9B | 14.4B |
| Basic EPS | 36 | — | — | — |
| Diluted EPS | 36 | — | — | — |
| Basic average shares | 1.4B | — | — | — |
| Diluted average shares | 1.4B | — | — | — |
| EBITDA | 83.6B | 113.6B | 62.9B | 73.3B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -1.1B | -609.0M | 783.4M | -1.1B |
| Preferred stock dividends | 0 | 0 | 0 | 0 |